AlloMek Therapeutics allomek.optimatrix.net


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

AlloMek Therapeutics, formerly AlloStem Therapeutics, is an early-stage pharmaceutical company committed to helping cancer patients by developing macrocyclic small molecule inhibitors that target various pathways involved in the development of cancer. The first such macrocyclic lead compound and advanced preclinical candidate, CIP-137401, is a potent inhibitor of the clinically validated MEK pathway, which is important in the regulation, proliferation, differentiation, development and survival o...Show all

AlloMek Therapeutics, formerly AlloStem Therapeutics, is an early-stage pharmaceutical company committed to helping cancer patients by developing macrocyclic small molecule inhibitors that target various pathways involved in the development of cancer...Show all

Company (Alive / Active)

Phone: 860-679-358

Fax:

400 Farmington Avenue

Farmington, 06030
Connecticut, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
AlloMek Therapeutics $0.5M Feb 6, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related AlloMek Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Novel mek inhibitors for treating cardiomyopathies and related conditions Apr 10, 2015 Application